NO20030515L - Fremgangsmåte for fremstilling av dinapsolin - Google Patents

Fremgangsmåte for fremstilling av dinapsolin

Info

Publication number: NO20030515L
Authority: NO; Norway
Prior art keywords: dinapsoline; preparation
Prior art date: 2000-08-11

Application number

NO20030515A

Other languages

English (en)

Other versions

NO20030515D0 (no

Inventor

Sing-Yuen Sit

Swanee Jacutin-Porte

Original Assignee

Purdue Research Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-11

Filing date

2003-02-03

Publication date

2003-03-31

2003-02-03 Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation

2003-02-03 Publication of NO20030515D0 publication Critical patent/NO20030515D0/no

2003-03-31 Publication of NO20030515L publication Critical patent/NO20030515L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20030515A 2000-08-11 2003-02-03 Fremgangsmåte for fremstilling av dinapsolin NO20030515L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22496800P	2000-08-11	2000-08-11
PCT/US2001/025265 WO2002013827A1 (en)	2000-08-11	2001-08-10	Process for the preparation of dinapsoline

Publications (2)

Publication Number	Publication Date
NO20030515D0 NO20030515D0 (no)	2003-02-03
NO20030515L true NO20030515L (no)	2003-03-31

Family

ID=22842980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030515A NO20030515L (no)	2000-08-11	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin

Country Status (12)

Country	Link
US (1)	US6645975B1 (no)
EP (1)	EP1320367A4 (no)
JP (1)	JP2004506014A (no)
KR (1)	KR20030027020A (no)
CN (1)	CN1473045A (no)
AU (2)	AU8824201A (no)
BR (1)	BR0113170A (no)
CA (1)	CA2417807A1 (no)
MX (1)	MXPA03001272A (no)
NO (1)	NO20030515L (no)
NZ (1)	NZ524212A (no)
WO (1)	WO2002013827A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60220800D1 (de) *	2001-08-10	2007-08-02	Purdue Research Foundation	Chirales dinapsolin
FR3017868A1 (fr) *	2014-02-21	2015-08-28	Servier Lab	Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2020005366A (es)	2017-11-24	2020-08-13	H Lundbeck As	Nuevos profarmacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson.
US11111263B2 (en)	2019-05-20	2021-09-07	H. Lundbeck A/S	Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en)	2019-05-20	2021-08-31	H. Lundbeck A/S	Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en)	2019-05-20	2021-11-09	H. Lundbeck A/S	Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11130775B2 (en)	2019-05-20	2021-09-28	H. Lundbeck A/S	Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
WO2020234275A1 (en)	2019-05-21	2020-11-26	H. Lundbeck A/S	New catecholamine prodrugs for use in the treatment of parkinson's diseases
WO2020234277A1 (en)	2019-05-21	2020-11-26	H. Lundbeck A/S	Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease
CN113727974B (zh)	2019-05-21	2025-01-07	H.隆德贝克有限公司	用于治疗帕金森病的新儿茶酚胺前药
EP3972970A1 (en)	2019-05-21	2022-03-30	H. Lundbeck A/S	New catecholamine prodrugs for use in the treatment of parkinson's disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK297275A (da) *	1974-08-07	1976-02-08	Aspro Nicholas Ltd	Isoquinolinderivater
CA1033358A (en) *	1974-09-03	1978-06-20	Ayerst, Mckenna And Harrison Limited	Benzo(4,5)(1,2,3-ij)isoquinolines and process therefor
IL122974A (en) *	1995-08-18	2000-11-21	Purdue Research Foundation	Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them
EP0883609A1 (en) *	1996-02-23	1998-12-16	Pharmeco Laboratories, Inc.	Selective d1 dopamine receptor agonists and partial agonists/antagonists

2001
- 2001-08-10 AU AU8824201A patent/AU8824201A/xx active Pending
- 2001-08-10 CN CNA018166903A patent/CN1473045A/zh active Pending
- 2001-08-10 AU AU2001288242A patent/AU2001288242B2/en not_active Ceased
- 2001-08-10 JP JP2002518970A patent/JP2004506014A/ja not_active Withdrawn
- 2001-08-10 KR KR10-2003-7001975A patent/KR20030027020A/ko not_active Ceased
- 2001-08-10 US US10/343,037 patent/US6645975B1/en not_active Expired - Fee Related
- 2001-08-10 MX MXPA03001272A patent/MXPA03001272A/es not_active Application Discontinuation
- 2001-08-10 BR BR0113170-2A patent/BR0113170A/pt not_active Application Discontinuation
- 2001-08-10 WO PCT/US2001/025265 patent/WO2002013827A1/en not_active Ceased
- 2001-08-10 EP EP01967963A patent/EP1320367A4/en not_active Withdrawn
- 2001-08-10 CA CA002417807A patent/CA2417807A1/en not_active Abandoned
- 2001-08-10 NZ NZ524212A patent/NZ524212A/en unknown
2003
- 2003-02-03 NO NO20030515A patent/NO20030515L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0113170A (pt)	2004-01-06
WO2002013827A1 (en)	2002-02-21
US6645975B1 (en)	2003-11-11
CA2417807A1 (en)	2002-02-21
EP1320367A4 (en)	2007-01-17
AU8824201A (en)	2002-02-25
NZ524212A (en)	2004-07-30
CN1473045A (zh)	2004-02-04
MXPA03001272A (es)	2004-04-02
EP1320367A1 (en)	2003-06-25
AU2001288242B2 (en)	2005-11-17
JP2004506014A (ja)	2004-02-26
NO20030515D0 (no)	2003-02-03
KR20030027020A (ko)	2003-04-03

Publication	Publication Date	Title
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
CY2007029I1 (el)	2009-11-04	Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20013943D0 (no)	2001-08-14	Fremgangsmate for fremstilling av Citalopram
FI20011578A0 (fi)	2001-07-26	Menetelmä puhtaan sitalopraamin valmistamiseksi
NO20011271A (no)	2002-05-13	Fremgangsmåte for fremstilling av ren citalopram
NO20030163L (no)	2003-02-27	Fremgangsmate for fremstilling av olefiner
NO20040027L (no)	2004-01-05	Fremgangsmate for fremstillingen av escitalopram
FI20011541A0 (fi)	2001-07-13	Menetelmä massan valmistamiseksi
NO20032731D0 (no)	2003-06-16	Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20031413D0 (no)	2003-03-27	Ny fremgangsmåte for fremstilling av oksabispidiner
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20025423L (no)	2002-11-12	Fremgangsmate for fremstilling av Citalopram
NO20023445L (no)	2003-01-20	Fremgangsmåte for fremstilling av peptider
NO20026155D0 (no)	2002-12-20	Fremgangsmåte for fremstilling av lavere olefiner
NO20021118D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av citalopram
NO20025465L (no)	2003-01-20	Fremgangsmåte for fremstilling av bifenylforbindelser
NO20024887L (no)	2002-10-10	FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702L (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20032297D0 (no)	2003-05-21	Fremgangsmåte for fremstilling av distamycinderivater
NO20025385D0 (no)	2002-11-11	FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
NO20035138D0 (no)	2003-11-18	Fremgangsmåte til fremstilling av amorft natriumsilastatin

Legal Events

Date	Code	Title	Description
2008-03-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application